$TER

MATZ MARILYN sold $510K of TER

MATZ MARILYN sold 1,200 shares of TERADYNE, INC (TER) at $425.00 ($0.51M total) on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MATZ MARILYN
Published Aug 18, 2026, 3:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 4:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
medium confidence
Mentioned
$TER
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The disclosed event is an open-market sale by a director under a pre-arranged 10b5-1 plan, which typically has limited incremental informational content for trading.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure suggests it is not a new fundamental signal.

03

What to watch

The article provides no context on total insider holdings changes beyond post-sale shares, no reason for sale, and no concurrent operational or financial catalysts.

Relevance 4/10Novelty 3/10Timing: today’s SEC Form 4 filing (filed 2026-08-18)

Background

The article is an SEC Form 4 insider transaction disclosure for Teradyne, Inc.

Company-level read

Ticker impact

$TERNeutralMedium confidence
Context

Teradyne director MatZ Marilyn sold 1,200 shares at $425 on 2026-08-17 under a pre-arranged 10b5-1 plan, totaling $510,000.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief unless paired with other company-specific news.

Evidence & confidence

Form 4 insider sales are common and the filing explicitly states a pre-arranged 10b5-1 plan, which reduces interpretability as new negative information.

Market effects

No sector read-through is provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

A large dollar insider sale can still be interpreted as confidence in liquidity needs or diversification, but the 10b5-1 designation weakens the bearish inference.

Key entities

  • TERADYNE, INC

    US-listed company whose director filed the Form 4 for an insider sale.

  • MATZ MARILYN

    Director who sold 1,200 shares at $425 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TERHigh

Why is Teradyne stock sliding today?

Teradyne (TER) stock fell 3.9% after Baird downgraded it to Neutral with a $420 price target, citing stretched valuation and concerns over AI and hyperscaler spending sustainability. The firm argues GPU testing catalyst is priced in and next growth drivers are too distant. TER's decline contrasts with broader market gains, highlighting company-specific pressures.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.

$OUSTMed

Robotics Stocks Rally as Unitree’s 8000X Oversubscribed IPO Draws Frenzied Demand: Ouster, Symbotic, and Teradyne in Focus

Robotics and physical AI stocks rose after China’s Unitree Robotics Shanghai IPO reportedly drew 8,000x retail oversubscription. In U.S. trading, Ouster gained 7% near $45, Symbotic rose 3% to about $41, and Teradyne added 3% to about $376. Ouster reported Q2 revenue of $54.63M (+55.9% YoY) and 17,000+ sensors; Symbotic has a ~$22.5B backlog. Analysts’ consensus targets cited $58 for OUST and $450 for TER.

$TERMed

5 Revealing Analyst Questions From Teradyne’s Q2 Earnings Call

Teradyne reported Q2 revenue of $1.33B vs $1.22B expected and adjusted EPS of $2.47 vs $2.05, citing AI-driven demand across semiconductor test, product test, and robotics. CEO Gregory Smith said over 60% of revenue is AI-related. Q3 guidance calls for $1.25B revenue and $2.00 adjusted EPS at midpoint. Analysts asked about test equipment share, wafer-to-data-center strategy, memory drivers, and CPU vs GPU testing.